Literature DB >> 16361001

Progress in the control of hepatitis B infection in the Western Pacific Region.

C John Clements1, Yang Baoping, Alan Crouch, David Hipgrave, Osman Mansoor, Christopher B Nelson, Sophie Treleaven, Ronald van Konkelenberg, Steven Wiersma.   

Abstract

Hepatitis B virus infection is a serious problem globally, and particularly in the Western Pacific Region where the population suffers disproportionately from the infection and its sequelae. By 2001, every immunization programme in the Region had included hepatitis B vaccine in their schedule. However, many challenges remain if every one of the 26 million children born in the 37 countries and areas of the Region each year is to be protected against hepatitis B infection. In 2003, the Regional Committee of the World Health Organization's Western Pacific Region resolved to improve hepatitis B control by making it one of two new pillars for strengthening the Expanded Programme on Immunization. The Committee endorsed the strategies of the Regional Plan to improve hepatitis B control through immunization, reducing chronic HBV infection (chronic carriage rate) to less than 1%, and aiming for coverage of at least 80% of the birth cohort in every district with three doses of hepatitis B vaccine by 2005. To help guide this process, an assessment was made of the progress to date, and is reported in this paper. Coverage data used in this evaluation were not independently verified, and could over-estimate progress made in some countries. Whilst there has indeed been great progress in the Region, a number of national programmes still lack the ability to reach all children with immunization services. Other major issues that need to be addressed are the challenges of delivering a timely birth dose, and for certain countries, the affordability of the vaccine over the short- and long-term.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361001     DOI: 10.1016/j.vaccine.2005.11.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant.

Authors:  Priyo Budi Purwono; Mochamad Amin; Rendra Bramanthi; Erika Maria Resi; Rury Mega Wahyuni; Yoshihiko Yano; Hak Hotta; Yoshitake Hayashi; Takako Utsumi; Maria Inge Lusida
Journal:  Am J Trop Med Hyg       Date:  2016-07-11       Impact factor: 2.345

2.  Too much of a good thing? When to stop catch-up vaccination.

Authors:  David W Hutton; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2013-07-15       Impact factor: 2.583

3.  Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia.

Authors:  Shuaibu A Hudu; Nabil S Harmal; Mohammed I Saeed; Ahmad S Alshrari; Yasmin A Malik; Mohd T Niazlin; Roshida Hassan; Zamberi Sekawi
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

4.  Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.

Authors:  David W Hutton; Samuel K So; Margaret L Brandeau
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

5.  Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications.

Authors:  Manju Rani; Baoping Yang; Richard Nesbit
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

6.  Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.

Authors:  Bunsoth Mao; Minal K Patel; Karen Hennessey; Richard J W Duncan; Kathleen Wannemuehler; Sann Chan Soeung
Journal:  Vaccine       Date:  2013-05-15       Impact factor: 3.641

7.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

8.  Hepatitis B Vaccination Coverage and Prevalence of Hepatitis B Surface Antigen Among Children in French Polynesia, 2014.

Authors:  Minal K Patel; Evelyne Le Calvez; Kathleen Wannemuehler; Jean-Marc Ségalin
Journal:  Am J Trop Med Hyg       Date:  2016-03-21       Impact factor: 2.345

9.  Progress towards achieving hepatitis B control in the Cook Islands, Niue, Tokelau, and Kiribati.

Authors:  Minal K Patel; Kathleen Wannemuehler; Rangi Tairi; Rufina Tutai; Edna Moturi; Beia Tabwaia; Akineti Bauro Nikuata; Malae Fepuleai Etuale; Grizelda Mokoia
Journal:  Vaccine       Date:  2016-07-08       Impact factor: 3.641

10.  A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination.

Authors:  Tran Hien Nguyen; Minh Huong Vu; Van Cuong Nguyen; Lien Huong Nguyen; Kohei Toda; Tuyet Nga Nguyen; Sang Dao; Kathleen A Wannemuehler; Karen A Hennessey
Journal:  Vaccine       Date:  2013-11-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.